SKIBSTED RUSSELL
SEC CIK 1308105 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PCSA | Processa Pharmaceuticals, Inc. | CFO | 16.7K | $41.7K | — | 7 | 2026-03-31 | 2026-06-30 |
Most active insiders at PCSA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ng George K | CEO, Dir | $55.0K | — |
| 2 | SKIBSTED RUSSELL | CFO | $41.7K | — |
| 3 | Guy Wendy | Chief Administrative Off | $32.9K | — |
| 4 | Young David | Pres. Research, Development, Dir | $32.4K | — |
| 5 | Lin Patrick | Chief Business - Strategy Off | $28.5K | — |
| 6 | Bigora Sian | Chief Development Off | $21.4K | — |
| 7 | Baluch Khoso | Dir | $5,752 | — |
| 8 | Pannu Geraldine | Dir | $5,253 | — |
| 9 | Neal James R | Dir | $2,000 | — |
| 10 | Yorke Justin W | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-01 16:17 | 2026-06-30 | PCSA | Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL | CFO | P - Purchase | $1.93 | +3,277 | 16.7K | +24% | +$6,325 | |
| 2026-06-16 16:23 | 2026-06-15 | PCSA | Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL | CFO | P - Purchase | $2.22 | +2,654 | 13.4K | +25% | +$5,892 | |
| 2026-06-01 16:59 | 2026-05-29 | PCSA | Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL | CFO | P - Purchase | $2.57 | +2,292 | 10.8K | +27% | +$5,890 | |
| 2026-05-19 17:35 | 2026-05-15 | PCSA | Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL | CFO | P - Purchase | $2.97 | +1,984 | 8,466 | +31% | +$5,892 | |
| 2026-05-01 16:38 | 2026-04-30 | PCSA | Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL | CFO | P - Purchase | $2.69 | +2,190 | 6,498 | +51% | +$5,891 | |
| 2026-04-17 16:49 | 2026-04-15 | PCSA | Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL | CFO | P - Purchase | $2.97 | +1,984 | 4,308 | +85% | +$5,892 | |
| 2026-04-01 17:18 | 2026-03-31 | PCSA | Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL | CFO | P - Purchase | $2.54 | +2,324 | 2,324 | New | +$5,891 |
Purchase Sale Sale after option exercise All abbreviations